1. NIH mulls rules for validating key results;M. Wadman;Nature,2013
2. E. Baum, N. Littman, M. Ruffin, S. Ward, K. Aschheim, Key Tools and Technology Hurdles in Advancing Stem-Cell Therapies, California Institute for Regenerative Medicine, 2013. http://alliancerm.org/sites/default/files/Key%20Tools%20and%20Tech%20Hurdles%20in%20Advancing%20Stem%20Cell%20Therapies.pdf (accessed October 7, 2016).
3. Critical elements in the development of cell therapy potency assays for ischemic conditions;Y. Porat;Cytotherapy
4. Pharma and Biotech Survey, Alliance for Regenerative Medicine, 2014. http://alliancerm.org/sites/default/files/ARM_Pharma_SurveyRept_Mar2014_e.pdf (accessed October 7, 2016).
5. Drug development: Raise standards for preclinical cancer research;C.G. Begley;Nature,2012